Notch3 and pre‐TCR interaction unveils distinct NF‐κB pathways in T‐cell development and leukemia
暂无分享,去创建一个
I. Screpanti | L. Frati | A. Gulino | M. P. Felli | R. Palermo | G. Di Mario | A. Vacca | M. Di Giovine | A. Calce | Giuseppina Di Mario
[1] Liwu Li,et al. Endotoxin Tolerance Disrupts Chromatin Remodeling and NF-κB Transactivation at the IL-1β Promoter1 , 2005, The Journal of Immunology.
[2] G. Xiao,et al. Essential Role of IκB Kinase α in the Constitutive Processing of NF-κB2 p100* , 2005, Journal of Biological Chemistry.
[3] Malay Mandal,et al. The BCL2A1 gene as a pre–T cell receptor–induced regulator of thymocyte survival , 2005, The Journal of experimental medicine.
[4] I. Screpanti,et al. PKCθ mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia , 2005, Oncogene.
[5] B. Aronow,et al. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers , 2004 .
[6] Sankar Ghosh,et al. Signaling to NF-kappaB. , 2004, Genes & development.
[7] M. Karin,et al. The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .
[8] G. Xiao,et al. Induction of p100 Processing by NF-κB-inducing Kinase Involves Docking IκB Kinase α (IKKα) to p100 and IKKα-mediated Phosphorylation* , 2004, Journal of Biological Chemistry.
[9] A. Sarin,et al. The Anti-apoptotic Effect of Notch-1 Requires p56lck-dependent, Akt/PKB-mediated Signaling in T Cells* , 2004, Journal of Biological Chemistry.
[10] A. F. Campese,et al. Pre‐TCR‐triggered ERK signalling‐dependent downregulation of E2A activity in Notch3‐induced T‐cell lymphoma , 2003, EMBO reports.
[11] D. Green,et al. RelB/p50 dimers are differentially regulated by TNF-α and lymphotoxin-β receptor activation: critical roles for p100 , 2003 .
[12] F. Weih,et al. RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.
[13] William Arbuthnot Sir Lane,et al. NF-κB2 p100 is a pro-apoptotic protein with anti-oncogenic function , 2002, Nature Cell Biology.
[14] D. Green,et al. The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .
[15] Gioacchino Natoli,et al. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. , 2002, Genes & development.
[16] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[17] U. Lendahl,et al. Combined expression of pTα and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[18] Michael Karin,et al. NF-κB at the crossroads of life and death , 2002, Nature Immunology.
[19] Michael Karin,et al. Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.
[20] L. Scorrano,et al. Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT , 2001, Nature Immunology.
[21] U. Lendahl,et al. Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice , 2000, The EMBO journal.
[22] W. Greene,et al. Activation of the Heterodimeric IκB Kinase α (IKKα)-IKKβ Complex Is Directional: IKKα Regulates IKKβ under Both Basal and Stimulated Conditions , 2000, Molecular and Cellular Biology.
[23] H. Fehling,et al. Crucial role of the pre-T-cell receptor α gene in development of ap but not γδ T cells , 1995, Nature.
[24] C. Ware,et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.
[25] D. Carrasco,et al. Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen. , 1994, Oncogene.
[26] D. Smith,et al. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.
[27] I. Screpanti,et al. PKC theta mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia. , 2005, Oncogene.
[28] G. Xiao,et al. Essential role of IkappaB kinase alpha in the constitutive processing of NF-kappaB2 p100. , 2005, The Journal of biological chemistry.
[29] Liwu Li,et al. Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. , 2005, Journal of Immunology.
[30] M. Karin,et al. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. , 2004, Trends in immunology.
[31] B. Aronow,et al. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. , 2004, The EMBO journal.
[32] D. Green,et al. RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100. , 2003, The Journal of biological chemistry.
[33] William Arbuthnot Sir Lane,et al. NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function. , 2002, Nature cell biology.
[34] D. Green,et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. , 2002, Immunity.
[35] Michael Karin,et al. NF-kappaB in cancer: from innocent bystander to major culprit. , 2002, Nature reviews. Cancer.
[36] Michael Karin,et al. NF-kappaB at the crossroads of life and death. , 2002, Nature immunology.
[37] M. Karin,et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. , 2001, Science.
[38] H. Fehling,et al. Crucial role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. , 1995, Nature.